|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000110092 |
Summary for CCND1 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000110092 | Gene symbol | CCND1 |
| Gene name | cyclin D1 | |
| HGNC | 1582 | |
| Entrez ID | 595 | |
| Gene type | protein_coding | |
| Synonyms | CCND1|U21B31 | |
| UniProtAcc | P24385 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| ENSG00000110092 | CCND1 | DB00945 | Acetylsalicylic acid | SmallMoleculeDrug |
| ENSG00000110092 | CCND1 | DB01169 | Arsenic trioxide | SmallMoleculeDrug |
| ENSG00000110092 | CCND1 | DB11718 | Encorafenib | SmallMoleculeDrug |
| ENSG00000110092 | CCND1 | DB11752 | Bryostatin 1 | SmallMoleculeDrug |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
| ENSG00000110092 | CCND1 | DB01169 | Arsenic trioxide | SmallMoleculeDrug | Acute Myeloid Leukemia (AML),Myeloproliferative Neoplasms |
| ENSG00000110092 | CCND1 | DB11718 | Encorafenib | SmallMoleculeDrug | Melanoma,Melanoma |
Top |
Structure and expression level for CCND1 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| CCND1 | 3.55e+04 | 1.20e+00 | 3.99e-01 | 3.01e+00 | 2.65e-03 | 2.28e-02 | BRCA |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| CCND1 | 1.50e+04 | 1.17e+00 | 5.05e-01 | 2.31e+00 | 2.09e-02 | 4.46e-02 | BLCA |
| CCND1 | 3.56e+04 | 1.27e+00 | 4.72e-01 | 2.69e+00 | 7.05e-03 | 2.89e-02 | ESCA |
| Differentially expressed gene analysis between tumor female and normal female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| CCND1 | 3.30e+04 | 1.28e+00 | 1.32e-01 | 9.71e+00 | 2.82e-22 | 1.05e-21 | BRCA |
| CCND1 | 7.57e+03 | 1.43e+00 | 2.51e-01 | 5.70e+00 | 1.20e-08 | 1.85e-07 | READ |
Top |
Sex-biased somatic mutation for CCND1 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for CCND1 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| ACC | cg00858899 | chr11:69640509 | CGI:chr11:69636368-69643828 | promoter | 1.31e-01 | 2.43e-01 | -2.57e+00 | 1.02e-02 | 2.57e-02 | -1.12e-01 |
| ACC | cg02255700 | chr11:69640506 | CGI:chr11:69636368-69643828 | promoter | 1.23e-01 | 2.43e-01 | -2.16e+00 | 3.09e-02 | 4.19e-02 | -1.20e-01 |
| ACC | cg05068533 | chr11:69640317 | CGI:chr11:69636368-69643828 | promoter | 1.35e-01 | 2.49e-01 | -2.63e+00 | 8.52e-03 | 2.34e-02 | -1.14e-01 |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| KIRC | cg15233880 | chr11:69639959 | CGI:chr11:69636368-69643828 | promoter | 1.80e-01 | 3.69e-01 | -2.66e+00 | 7.72e-03 | 9.49e-03 | -1.90e-01 |
| THCA | cg13720316 | chr11:69640343 | CGI:chr11:69636368-69643828 | promoter | 2.25e-01 | 3.27e-01 | -4.49e+00 | 7.24e-06 | 9.96e-05 | -1.03e-01 |
| THCA | cg11190277 | chr11:69640445 | CGI:chr11:69636368-69643828 | promoter | 1.44e-01 | 2.56e-01 | -4.21e+00 | 2.58e-05 | 2.34e-04 | -1.12e-01 |
| THCA | cg07781399 | chr11:69640519 | CGI:chr11:69636368-69643828 | promoter | 1.07e-01 | 2.32e-01 | -5.07e+00 | 3.88e-07 | 1.60e-05 | -1.25e-01 |
| HNSC | cg11398323 | chr11:69639928 | CGI:chr11:69636368-69643828 | promoter | 1.92e-01 | 3.01e-01 | -2.46e+00 | 1.41e-02 | 1.71e-02 | -1.09e-01 |
| LUSC | cg24387864 | chr11:69640055 | CGI:chr11:69636368-69643828 | promoter | 2.12e-01 | 3.19e-01 | -2.80e+00 | 5.07e-03 | 8.24e-03 | -1.07e-01 |
| BLCA | cg15233880 | chr11:69639959 | CGI:chr11:69636368-69643828 | promoter | 1.53e-01 | 3.59e-01 | -2.65e+00 | 8.12e-03 | 1.20e-02 | -2.06e-01 |
| BLCA | cg07781399 | chr11:69640519 | CGI:chr11:69636368-69643828 | promoter | 1.04e-01 | 2.52e-01 | -4.90e+00 | 9.73e-07 | 6.20e-05 | -1.48e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg11398323 | chr11:69639928 | CGI:chr11:69636368-69643828 | promoter | 1.37e-01 | 2.63e-01 | -2.78e+00 | 5.36e-03 | 6.32e-03 | -1.26e-01 |
| BRCA | cg15233880 | chr11:69639959 | CGI:chr11:69636368-69643828 | promoter | 1.38e-01 | 2.44e-01 | -6.40e+00 | 1.57e-10 | 4.08e-10 | -1.06e-01 |
| THCA | cg15233880 | chr11:69639959 | CGI:chr11:69636368-69643828 | promoter | 4.21e-01 | 6.44e-01 | -3.04e+00 | 2.39e-03 | 4.50e-03 | -2.22e-01 |
Top |
Exon skipping events with PSI in TCGA for CCND1 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Landscape of exon skipping events across multiple cancer types. |
 |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for CCND1 |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for CCND1 |
| TFs related to CCND1. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| BRCA | PLAGL2 | CCND1 | 2.43e+00 | 1.65e-03 | 4.20e+00 | 9.81e-01 | Female-biased |
| BRCA | ZNF423 | CCND1 | 3.21e+00 | 8.83e-03 | 4.46e+00 | 9.80e-01 | Female-biased |
| ESCA | DNMT1 | CCND1 | 2.98e+00 | 5.15e-03 | 3.91e+00 | 9.82e-01 | Female-biased |
| CCND1 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for CCND1 |
| RBPs related to ES in CCND1. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| UVM | ZNF638 | exon_skip_62685 | 1.32e+01 | 9.99e-01 | 1.27e+01 | 5.39e-04 | Male-biased |
| LIHC | ZNF638 | exon_skip_62685 | 1.26e+01 | 7.36e-03 | 1.30e+01 | 9.92e-01 | Female-biased |
| COAD | SAMD4A | exon_skip_62685 | 6.27e+00 | 1.24e-03 | 6.81e+00 | 9.84e-01 | Female-biased |
| CHOL | ZNF638 | exon_skip_62685 | 1.29e+01 | 2.62e-03 | 1.35e+01 | 9.97e-01 | Female-biased |
| KIRP | ZNF638 | exon_skip_62685 | 1.32e+01 | 9.98e-01 | 1.27e+01 | 1.63e-03 | Male-biased |
| READ | ZNF638 | exon_skip_62685 | 1.26e+01 | 4.32e-03 | 1.30e+01 | 9.95e-01 | Female-biased |
| MESO | ZNF638 | exon_skip_62685 | 1.26e+01 | 1.96e-03 | 1.31e+01 | 9.98e-01 | Female-biased |
| GBM | ZNF638 | exon_skip_62685 | 1.31e+01 | 9.99e-01 | 1.25e+01 | 7.39e-04 | Male-biased |
| PAAD | SAMD4A | exon_skip_62685 | 6.72e+00 | 9.84e-01 | 6.16e+00 | 4.58e-04 | Male-biased |
| KIRC | SAMD4A | exon_skip_62685 | 6.19e+00 | 1.01e-04 | 6.99e+00 | 9.86e-01 | Female-biased |
| CCND1 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs34796507 | chr11:75291155:G:A | - | 0.165369990005965 | 0.0192394213545864 | SARC | Female-baised eQTL |
| rs35927438 | chr11:75291757:G:A | - | 0.165285514261939 | 0.0193694317237975 | SARC | Female-baised eQTL |
| rs77118314 | chr11:71276967:C:T | - | 0.223080952561631 | 7.34232078342577e-10 | LIHC | Female-baised eQTL |
| rs73538108 | chr11:71332308:A:G | - | 0.2200339412233 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs75025725 | chr11:71330003:T:C | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs77955206 | chr11:71330024:T:C | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs75759824 | chr11:71330096:T:C | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs76759696 | chr11:71330104:T:A | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs73536077 | chr11:71330323:A:T | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs76114565 | chr11:71330418:A:G | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs73536078 | chr11:71330491:C:T | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs73536084 | chr11:71330792:T:C | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs188263147 | chr11:71330944:A:T | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs75307791 | chr11:71330947:G:T | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs73536085 | chr11:71330960:G:A | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs73536086 | chr11:71331035:A:C | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs73536088 | chr11:71331055:C:A | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs73536090 | chr11:71331170:T:C | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs73536092 | chr11:71331198:A:G | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs73536094 | chr11:71331245:C:T | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs73536095 | chr11:71331312:T:C | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs73536097 | chr11:71331923:C:T | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs73536098 | chr11:71331955:G:A | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs73536101 | chr11:71332086:A:G | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs73536102 | chr11:71332096:G:A | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs73538109 | chr11:71332580:C:A | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs59280193 | chr11:71332757:G:A | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs59189114 | chr11:71332899:G:A | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs57066538 | chr11:71333336:G:A | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs61311656 | chr11:71333571:G:A | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs73538124 | chr11:71334326:A:G | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs76803517 | chr11:71334436:C:T | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs57657260 | chr11:71334474:A:C | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs57517830 | chr11:71334615:C:T | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs61189967 | chr11:71334686:A:G | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs73538127 | chr11:71335054:C:A | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs73538129 | chr11:71335281:T:G | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs78302243 | chr11:71335333:G:A | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs75707969 | chr11:71335669:A:G | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs75983795 | chr11:71335686:A:G | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs73538136 | chr11:71335919:C:T | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs73538142 | chr11:71337102:T:C | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs73538143 | chr11:71337147:C:T | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs73538145 | chr11:71337183:A:G | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs75145621 | chr11:71337188:A:T | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs76798069 | chr11:71337348:T:G | - | 0.219958080156883 | 1.98001198566156e-09 | LIHC | Female-baised eQTL |
| rs74532015 | chr11:71330942:G:A | - | 0.219883676572792 | 2.0934685734843e-09 | LIHC | Female-baised eQTL |
| rs73536068 | chr11:71328879:C:T | - | 0.198123996378733 | 8.80640087611964e-08 | LIHC | Female-baised eQTL |
| rs77950567 | chr11:71398406:G:A | - | 0.171656238597408 | 2.15032651550867e-06 | LIHC | Female-baised eQTL |
| rs80330263 | chr11:71398139:C:T | - | 0.171561956226833 | 2.17542908199415e-06 | LIHC | Female-baised eQTL |
| rs78875728 | chr11:71398262:G:A | - | 0.171561956226833 | 2.17542908199415e-06 | LIHC | Female-baised eQTL |
| rs78778926 | chr11:71356368:G:A | - | 0.157409248334593 | 2.04437203663866e-05 | LIHC | Female-baised eQTL |
| rs77324227 | chr11:71359677:A:T | - | 0.157409248334593 | 2.04437203663866e-05 | LIHC | Female-baised eQTL |
| rs76863281 | chr11:71372035:C:G | - | 0.157347746848344 | 2.04475681349965e-05 | LIHC | Female-baised eQTL |
| rs76278857 | chr11:71396178:C:A | - | 0.157347746848344 | 2.04475681349965e-05 | LIHC | Female-baised eQTL |
| rs78907373 | chr11:71375390:T:G | - | 0.157216741083094 | 2.12297816880092e-05 | LIHC | Female-baised eQTL |
| rs76705744 | chr11:71379892:T:G | - | 0.157216741083094 | 2.12297816880092e-05 | LIHC | Female-baised eQTL |
| rs76608810 | chr11:71380099:C:T | - | 0.157216741083094 | 2.12297816880092e-05 | LIHC | Female-baised eQTL |
| rs79044453 | chr11:71383763:G:A | - | 0.157216741083094 | 2.12297816880092e-05 | LIHC | Female-baised eQTL |
| rs75724846 | chr11:71387130:G:A | - | 0.157216741083094 | 2.12297816880092e-05 | LIHC | Female-baised eQTL |
| rs79607581 | chr11:71387427:A:G | - | 0.157216741083094 | 2.12297816880092e-05 | LIHC | Female-baised eQTL |
| rs2924696 | chr11:68820269:T:C | - | -0.15944087683459 | 4.85363807620325e-05 | LIHC | Female-baised eQTL |
| rs76858186 | chr11:71314678:T:G | - | 0.148536608989576 | 5.02996057725003e-05 | LIHC | Female-baised eQTL |
| rs57365040 | chr11:71319554:T:C | - | 0.148536608989576 | 5.02996057725003e-05 | LIHC | Female-baised eQTL |
| rs17161403 | chr11:71323860:A:G | - | 0.148518223709029 | 5.12212021172751e-05 | LIHC | Female-baised eQTL |
| rs79913732 | chr11:71360229:C:T | - | 0.146907110666467 | 7.49447070607646e-05 | LIHC | Female-baised eQTL |
| rs77987943 | chr11:71364377:C:A | - | 0.146907110666467 | 7.49447070607646e-05 | LIHC | Female-baised eQTL |
| rs76480168 | chr11:71358911:C:G | - | 0.146343895187259 | 8.6737141302179e-05 | LIHC | Female-baised eQTL |
| rs146462379 | chr11:68692520:C:T | - | 0.136350378361363 | 0.000332270278644394 | LIHC | Female-baised eQTL |
| rs78097986 | chr11:68695350:C:T | - | 0.136350378361363 | 0.000332270278644394 | LIHC | Female-baised eQTL |
| rs59401354 | chr11:78977435:C:T | - | 0.130375289983613 | 0.000555956072073213 | LIHC | Female-baised eQTL |
| rs12577866 | chr11:78970208:C:T | - | 0.12457973195419 | 0.00065990060170256 | LIHC | Female-baised eQTL |
| rs2924675 | chr11:68798780:G:A | - | -0.129357531170968 | 0.000755190317336099 | LIHC | Female-baised eQTL |
| rs3019607 | chr11:68818518:C:A | - | -0.135295282478155 | 0.00101638760950317 | LIHC | Female-baised eQTL |
| rs3019608 | chr11:68818586:C:T | - | -0.135295282478155 | 0.00101638760950317 | LIHC | Female-baised eQTL |
| rs2924698 | chr11:68818922:C:T | - | -0.135295282478155 | 0.00101638760950317 | LIHC | Female-baised eQTL |
| rs3019611 | chr11:68820547:G:T | - | -0.135295282478155 | 0.00101638760950317 | LIHC | Female-baised eQTL |
| rs7480689 | chr11:68821127:T:C | - | -0.135295282478155 | 0.00101638760950317 | LIHC | Female-baised eQTL |
| rs7483929 | chr11:68821216:A:G | - | -0.135295282478155 | 0.00101638760950317 | LIHC | Female-baised eQTL |
| rs3019612 | chr11:68821583:G:A | - | -0.135295282478155 | 0.00101638760950317 | LIHC | Female-baised eQTL |
| rs3019610 | chr11:68820504:G:A | - | 0.135295282478155 | 0.00101638760950317 | LIHC | Female-baised eQTL |
| rs3136545 | chr11:68693270:C:T | - | 0.127359734435156 | 0.00108464864658378 | LIHC | Female-baised eQTL |
| rs79946709 | chr11:68694605:C:T | - | 0.127359734435156 | 0.00108464864658378 | LIHC | Female-baised eQTL |
| rs1943496 | chr11:68702838:G:A | - | 0.127359734435156 | 0.00108464864658378 | LIHC | Female-baised eQTL |
| rs2924672 | chr11:68764605:G:C | - | 0.130853667371409 | 0.00113192782756869 | LIHC | Female-baised eQTL |
| rs3019596 | chr11:68764920:G:A | - | -0.130853667371409 | 0.00113192782756869 | LIHC | Female-baised eQTL |
| rs2924671 | chr11:68765137:A:G | - | -0.130853667371409 | 0.00113192782756869 | LIHC | Female-baised eQTL |
| rs11237666 | chr11:78970010:C:T | - | 0.117512019025489 | 0.00167105749646894 | LIHC | Female-baised eQTL |
| rs75375721 | chr11:71354414:G:A | - | 0.120189864378738 | 0.00168221068339061 | LIHC | Female-baised eQTL |
| rs1840272 | chr11:68792208:A:G | - | -0.121164994917995 | 0.00198484786702197 | LIHC | Female-baised eQTL |
| rs4930612 | chr11:68797850:T:C | - | -0.12114093891405 | 0.00201050098413123 | LIHC | Female-baised eQTL |
| rs3019604 | chr11:68799722:A:C | - | -0.12114093891405 | 0.00201050098413123 | LIHC | Female-baised eQTL |
| rs2924699 | chr11:68762789:C:T | - | 0.120030836622081 | 0.00264918149721627 | LIHC | Female-baised eQTL |
| rs3019597 | chr11:68761890:C:T | - | -0.119742105991793 | 0.00286680230384878 | LIHC | Female-baised eQTL |
| rs74976810 | chr11:60512586:A:T | - | 0.11717377528935 | 0.00318301301463509 | LIHC | Female-baised eQTL |
| rs76701960 | chr11:60514046:G:C | - | 0.11717377528935 | 0.00318301301463509 | LIHC | Female-baised eQTL |
| rs3019593 | chr11:68771471:C:T | - | -0.120805074271964 | 0.00416853654364302 | LIHC | Female-baised eQTL |
| rs2924692 | chr11:68778410:T:A | - | -0.120805074271964 | 0.00416853654364302 | LIHC | Female-baised eQTL |
| rs3019590 | chr11:68778415:G:A | - | -0.120805074271964 | 0.00416853654364302 | LIHC | Female-baised eQTL |
| rs76413987 | chr11:78975342:A:C | - | 0.11035910023296 | 0.00433095714317077 | LIHC | Female-baised eQTL |
| rs1946700 | chr11:78975530:T:C | - | 0.11035910023296 | 0.00433095714317077 | LIHC | Female-baised eQTL |
| rs11237672 | chr11:78978008:G:A | - | 0.110334120077367 | 0.00438558508971301 | LIHC | Female-baised eQTL |
| rs7131392 | chr11:78980648:G:A | - | 0.110327981741574 | 0.00438558508971301 | LIHC | Female-baised eQTL |
| rs79650577 | chr11:78982776:C:T | - | 0.110327981741574 | 0.00438558508971301 | LIHC | Female-baised eQTL |
| rs57638434 | chr11:68779485:A:G | - | 0.120268567411148 | 0.00448294753061687 | LIHC | Female-baised eQTL |
| rs4261294 | chr11:68781551:T:C | - | -0.120121181438113 | 0.00465951315914318 | LIHC | Female-baised eQTL |
| rs3019584 | chr11:68814320:T:G | - | -0.115332885802083 | 0.00466169062790755 | LIHC | Female-baised eQTL |
| rs2924679 | chr11:68789314:G:A | - | 0.113153874955883 | 0.00528341344900024 | LIHC | Female-baised eQTL |
| rs2924678 | chr11:68791646:T:C | - | -0.113153874955883 | 0.00528341344900024 | LIHC | Female-baised eQTL |
| rs76449929 | chr11:68713782:A:G | - | 0.111483661883944 | 0.00775337355354854 | LIHC | Female-baised eQTL |
| rs80053720 | chr11:68715439:C:T | - | 0.111483661883944 | 0.00775337355354854 | LIHC | Female-baised eQTL |
| rs78115141 | chr11:68716826:C:A | - | 0.111483661883944 | 0.00775337355354854 | LIHC | Female-baised eQTL |
| rs373607814 | chr11:68718084:G:C | - | 0.111483661883944 | 0.00775337355354854 | LIHC | Female-baised eQTL |
| rs77910696 | chr11:68718356:C:T | - | 0.111483661883944 | 0.00775337355354854 | LIHC | Female-baised eQTL |
| rs76293388 | chr11:68723282:T:C | - | 0.111483661883944 | 0.00775337355354854 | LIHC | Female-baised eQTL |
| rs80260621 | chr11:68723627:G:C | - | 0.111483661883944 | 0.00775337355354854 | LIHC | Female-baised eQTL |
| rs75368595 | chr11:68724301:A:G | - | 0.111483661883944 | 0.00775337355354854 | LIHC | Female-baised eQTL |
| rs150450796 | chr11:68727181:C:G | - | 0.111483661883944 | 0.00775337355354854 | LIHC | Female-baised eQTL |
| rs74918018 | chr11:68746549:G:A | - | 0.111483661883944 | 0.00775337355354854 | LIHC | Female-baised eQTL |
| rs76209308 | chr11:68731166:T:G | - | 0.111527694298475 | 0.00778254267344298 | LIHC | Female-baised eQTL |
| rs77032016 | chr11:68733565:C:A | - | 0.111527694298475 | 0.00778254267344298 | LIHC | Female-baised eQTL |
| rs79100192 | chr11:68737504:C:T | - | 0.111527694298475 | 0.00778254267344298 | LIHC | Female-baised eQTL |
| rs3019578 | chr11:68788912:A:C | - | -0.107133623984992 | 0.00963644202809891 | LIHC | Female-baised eQTL |
| rs3019605 | chr11:68817878:G:A | - | -0.107866542226873 | 0.0108430973851933 | LIHC | Female-baised eQTL |
| rs3019606 | chr11:68817888:A:G | - | -0.107866542226873 | 0.0108430973851933 | LIHC | Female-baised eQTL |
| rs3019585 | chr11:68814446:G:A | - | -0.107758739712635 | 0.0110986611711529 | LIHC | Female-baised eQTL |
| rs2924687 | chr11:68814549:C:T | - | -0.107758739712635 | 0.0110986611711529 | LIHC | Female-baised eQTL |
| rs7112615 | chr11:68762850:C:A | - | -0.106882306506199 | 0.0111260433803771 | LIHC | Female-baised eQTL |
| rs79533882 | chr11:68720177:G:A | - | 0.0989345621614704 | 0.0308187913802299 | LIHC | Female-baised eQTL |
| rs3019576 | chr11:68780792:C:A | - | -0.100102818430438 | 0.0326016005304031 | LIHC | Female-baised eQTL |
| rs143722391 | chr11:63454740:A:C | - | 0.090989416057822 | 0.0354500797632719 | LIHC | Female-baised eQTL |
| rs75640100 | chr11:68164268:A:G | - | 0.0946410111259933 | 0.0361602132038185 | LIHC | Female-baised eQTL |
| rs77741961 | chr11:63459931:G:A | - | 0.0888445011768896 | 0.0382610961854475 | LIHC | Female-baised eQTL |
| rs79083860 | chr11:70158035:A:G | - | 0.127214483521428 | 0.00226523319661584 | BLCA | Female-baised eQTL |
| rs12790313 | chr11:70158888:G:A | - | 0.127214483521428 | 0.00226523319661584 | BLCA | Female-baised eQTL |
| rs1940236 | chr11:70150099:C:T | - | 0.124453512040275 | 0.0028927385793228 | BLCA | Female-baised eQTL |
| rs3781661 | chr11:70153527:C:T | - | 0.111121307300521 | 0.00775074494276393 | BLCA | Female-baised eQTL |
| rs10898819 | chr11:70152058:C:A | - | 0.110583418732997 | 0.0103056810281306 | BLCA | Female-baised eQTL |
| rs117278305 | chr11:71812515:G:A | - | 0.205572612120583 | 0.035069252051916 | BLCA | Female-baised eQTL |
| rs4945141 | chr11:77094731:A:G | - | 0.0527948486814393 | 0.00285522887566939 | LUAD | Female-baised eQTL |
| rs11828119 | chr11:77096697:A:G | - | 0.0525272177720391 | 0.00347815638099762 | LUAD | Female-baised eQTL |
| rs12223914 | chr11:64744414:G:T | - | 0.078012550893322 | 0.0235499104773674 | LUAD | Female-baised eQTL |
| rs686171 | chr11:64751873:G:A | - | 0.0777952792826641 | 0.0258800868034467 | LUAD | Female-baised eQTL |
| rs547066 | chr11:64756022:C:A | - | 0.0748413412702215 | 0.0361085619445137 | LUAD | Female-baised eQTL |
| rs569602 | chr11:64747034:A:G | - | 0.0741597047319458 | 0.0378695176011003 | LUAD | Female-baised eQTL |
| rs532747 | chr11:64751590:T:C | - | 0.0728543446347493 | 0.0423270040825095 | LUAD | Female-baised eQTL |
| rs592532 | chr11:64751045:T:C | - | 0.0699547456312938 | 0.0428276703978267 | LUAD | Female-baised eQTL |
| rs2071320 | chr11:64751048:C:T | - | 0.0699547456312938 | 0.0428276703978267 | LUAD | Female-baised eQTL |
| rs592521 | chr11:64751053:A:G | - | 0.0699547456312938 | 0.0428276703978267 | LUAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs113455597 | chr11:61981972:G:A | - | 0.16152890574888 | 0.00743604275618952 | SARC | Male-baised eQTL |
| rs77749926 | chr11:79391873:G:C | - | 0.105662569569872 | 0.0318429992981303 | LIHC | Male-baised eQTL |
| rs11237820 | chr11:79393621:G:A | - | 0.105662569569872 | 0.0318429992981303 | LIHC | Male-baised eQTL |
| rs4433593 | chr11:79395571:C:T | - | 0.105662569569872 | 0.0318429992981303 | LIHC | Male-baised eQTL |
| rs79822078 | chr11:79386980:C:T | - | 0.105796483431075 | 0.0378700358584919 | LIHC | Male-baised eQTL |
| rs2903910 | chr11:62267882:T:A | - | -0.0953794689509528 | 0.0444196203638915 | LIHC | Male-baised eQTL |
| rs12277834 | chr11:79389112:C:T | - | 0.100640734091016 | 0.0451013717410535 | LIHC | Male-baised eQTL |
| rs79406027 | chr11:79390059:G:T | - | 0.100640734091016 | 0.0451013717410535 | LIHC | Male-baised eQTL |
| rs12275195 | chr11:79394755:A:C | - | 0.100640734091016 | 0.0451013717410535 | LIHC | Male-baised eQTL |
| rs4515997 | chr11:79395340:A:G | - | 0.100640734091016 | 0.0451013717410535 | LIHC | Male-baised eQTL |
| rs11237821 | chr11:79395760:C:T | - | 0.100640734091016 | 0.0451013717410535 | LIHC | Male-baised eQTL |
| rs7108878 | chr11:79396763:T:G | - | 0.100640734091016 | 0.0451013717410535 | LIHC | Male-baised eQTL |
| rs4963488 | chr11:62271929:C:T | - | -0.0950550311515376 | 0.0459597137615933 | LIHC | Male-baised eQTL |
| rs11233933 | chr11:71499024:C:T | - | 0.0332920303253075 | 0.0278551459642641 | LUSC | Male-baised eQTL |
| rs10899226 | chr11:76496589:G:A | - | -0.0638372325534022 | 0.00200922066419318 | BLCA | Male-baised eQTL |
| rs11824538 | chr11:79203696:A:G | - | 0.0530026700334972 | 0.00288875912223047 | BLCA | Male-baised eQTL |
| rs56317934 | chr11:64599327:G:A | - | 0.0520562290046662 | 0.00614484819416108 | BLCA | Male-baised eQTL |
| rs11820030 | chr11:76422521:C:T | - | 0.0570013759435126 | 0.00673139507020104 | BLCA | Male-baised eQTL |
| rs3850944 | chr11:64709578:T:G | - | 0.0498657908311917 | 0.00712358739286017 | BLCA | Male-baised eQTL |
| rs200220771 | chr11:64594955:T:C | - | 0.0503777275856053 | 0.00884851179829895 | BLCA | Male-baised eQTL |
| rs17146104 | chr11:64603932:G:C | - | 0.0490063484245589 | 0.00909398853108638 | BLCA | Male-baised eQTL |
| rs3741399 | chr11:64606769:G:A | - | 0.0480124218218945 | 0.0107872541700149 | BLCA | Male-baised eQTL |
| rs375192466 | chr11:76582113:G:C | - | 0.0509195491381032 | 0.0176774791597344 | BLCA | Male-baised eQTL |
| rs3802947 | chr11:64608835:C:T | - | 0.0446767065433419 | 0.0187373359870107 | BLCA | Male-baised eQTL |
| rs59656013 | chr11:76579772:G:C | - | 0.0469568652013564 | 0.0193612972987118 | BLCA | Male-baised eQTL |
| rs7931495 | chr11:72521390:C:T | - | 0.0467099091873799 | 0.0206518875710056 | BLCA | Male-baised eQTL |
| rs11231841 | chr11:64610178:C:T | - | 0.0438676954755147 | 0.0213462930261072 | BLCA | Male-baised eQTL |
| rs11231842 | chr11:64620790:G:A | - | 0.0428823153620027 | 0.025614786219197 | BLCA | Male-baised eQTL |
| rs57387921 | chr11:64641244:C:T | - | 0.0428823153620027 | 0.025614786219197 | BLCA | Male-baised eQTL |
| rs11820322 | chr11:64645419:C:T | - | 0.0428823153620027 | 0.025614786219197 | BLCA | Male-baised eQTL |
| rs12226055 | chr11:64664721:G:A | - | 0.0428823153620027 | 0.025614786219197 | BLCA | Male-baised eQTL |
| rs11231849 | chr11:64665258:C:T | - | 0.0428823153620027 | 0.025614786219197 | BLCA | Male-baised eQTL |
| rs17134231 | chr11:75658308:C:T | - | 0.0435652335860921 | 0.0360587723422447 | BLCA | Male-baised eQTL |
| rs2905501 | chr11:61072106:T:C | - | -0.0425471670638128 | 0.0414465310695789 | BLCA | Male-baised eQTL |
| rs3019568 | chr11:61089561:C:T | - | 0.0363656838257413 | 0.0429796381413559 | BLCA | Male-baised eQTL |
| rs3016166 | chr11:61089725:A:G | - | 0.0363656838257413 | 0.0429796381413559 | BLCA | Male-baised eQTL |
| rs3016168 | chr11:61090823:C:A | - | 0.0363656838257413 | 0.0429796381413559 | BLCA | Male-baised eQTL |
| rs3019566 | chr11:61091125:C:T | - | 0.0363656838257413 | 0.0429796381413559 | BLCA | Male-baised eQTL |
| rs510715 | chr11:60847403:G:A | - | -0.0265437362676735 | 0.0444511957552362 | BLCA | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
 | Gene ID: ENSG00000110092 |
| CpG Site: cg06539449 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.414075420936367 | |
 | Gene ID: ENSG00000110092 |
| CpG Site: cg06539449 | |
| Position to Gene: gene | |
| Male Effect: -0.224719032226752 | |
| Female Effect: - | |
 | Gene ID: ENSG00000110092 |
| CpG Site: cg05068533 | |
| Position to Gene: promoter | |
| Male Effect: 0.205633681307642 | |
| Female Effect: - | |
 | Gene ID: ENSG00000110092 |
| CpG Site: cg07781399 | |
| Position to Gene: promoter | |
| Male Effect: 0.215634205609088 | |
| Female Effect: - | |
 | Gene ID: ENSG00000110092 |
| CpG Site: cg19209049 | |
| Position to Gene: promoter | |
| Male Effect: 0.214919509220335 | |
| Female Effect: - | |
 | Gene ID: ENSG00000110092 |
| CpG Site: cg04717045 | |
| Position to Gene: gene,exon,UTR | |
| Male Effect: -0.489734125202953 | |
| Female Effect: - | |
 | Gene ID: ENSG00000110092 |
| CpG Site: cg11802013 | |
| Position to Gene: gene,exon,UTR | |
| Male Effect: -0.195988808743158 | |
| Female Effect: - | |
 | Gene ID: ENSG00000110092 |
| CpG Site: cg25611369 | |
| Position to Gene: gene,enhancer | |
| Male Effect: -0.432943813847996 | |
| Female Effect: - | |
 | Gene ID: ENSG00000110092 |
| CpG Site: cg13608094 | |
| Position to Gene: gene | |
| Male Effect: -0.18760616686031 | |
| Female Effect: - | |
 | Gene ID: ENSG00000110092 |
| CpG Site: cg09637363 | |
| Position to Gene: gene,exon,enhancer,CDS | |
| Male Effect: -0.18379254247495 | |
| Female Effect: - | |
 | Gene ID: ENSG00000110092 |
| CpG Site: cg09520904 | |
| Position to Gene: gene,exon,UTR | |
| Male Effect: -0.107191771369865 | |
| Female Effect: - | |
 | Gene ID: ENSG00000110092 |
| CpG Site: cg06539449 | |
| Position to Gene: gene | |
| Male Effect: -0.0777394064815509 | |
| Female Effect: - |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg06539449 | chr11:69646240 | gene | -0.224719032226752 | 2.85313099317768e-06 | -0.3719925237523382 | 9.995716996873469e-09 | LUAD |
| cg05068533 | chr11:69640317 | promoter | 0.205633681307642 | 7.32003893744814e-07 | 0.36865864140327514 | 1.4552699504830175e-09 | LIHC |
| cg07781399 | chr11:69640519 | promoter | 0.215634205609088 | 4.72499338646129e-05 | 0.3199858253879643 | 1.972668562485863e-07 | LIHC |
| cg19209049 | chr11:69640061 | promoter | 0.214919509220335 | 5.14896963399188e-05 | 0.32049365874241115 | 7.243216636374823e-07 | LIHC |
| cg04717045 | chr11:69654021 | gene,exon,UTR | -0.489734125202953 | 3.87214870070006e-52 | -0.7730409080579795 | 4.292413192213799e-56 | LUSC |
| cg11802013 | chr11:69654407 | gene,exon,UTR | -0.195988808743158 | 8.55621388148671e-27 | -0.6208797511909876 | 8.231768499075138e-31 | LUSC |
| cg25611369 | chr11:69645870 | gene,enhancer | -0.432943813847996 | 2.35811243989552e-09 | -0.3853303003085377 | 1.1522847162888496e-11 | LGG |
| cg13608094 | chr11:69646468 | gene | -0.18760616686031 | 6.51958324093578e-07 | -0.3330466853388717 | 6.4834864496384e-09 | LGG |
| cg09637363 | chr11:69643876 | gene,exon,enhancer,CDS | -0.18379254247495 | 1.2533859718473e-06 | -0.32631470528579226 | 1.3506685574910944e-08 | LGG |
| cg09520904 | chr11:69648175 | gene,exon,UTR | -0.107191771369865 | 4.39007234596323e-10 | -0.4113006563744795 | 2.391023075095144e-13 | SKCM |
| cg06539449 | chr11:69646240 | gene | -0.0777394064815509 | 1.24517240213515e-08 | -0.37645818381554275 | 2.89876303471129e-11 | SKCM |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg06539449 | chr11:69646240 | gene | -0.414075420936367 | 3.45243906164865e-08 | -0.5262537915869556 | 7.619323331505276e-12 | COAD |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of CCND1 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000110092 | CCND1 | C0001418 | Adenocarcinoma | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0006079 | Bowen's Disease | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0006118 | Brain Neoplasms | 2 | CTD_human |
| ENSG00000110092 | CCND1 | C0006142 | Malignant neoplasm of breast | 6 | CTD_human |
| ENSG00000110092 | CCND1 | C0007097 | Carcinoma | 4 | CTD_human |
| ENSG00000110092 | CCND1 | C0007102 | Malignant tumor of colon | 4 | CTD_human |
| ENSG00000110092 | CCND1 | C0007137 | Squamous cell carcinoma | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0007138 | Carcinoma, Transitional Cell | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0007528 | Cecal Neoplasms | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0007621 | Neoplastic Cell Transformation | 2 | CTD_human |
| ENSG00000110092 | CCND1 | C0007873 | Uterine Cervical Neoplasm | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0009375 | Colonic Neoplasms | 4 | CTD_human |
| ENSG00000110092 | CCND1 | C0010606 | Adenoid Cystic Carcinoma | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0014170 | Endometrial Neoplasms | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0014859 | Esophageal Neoplasms | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0018923 | Hemangiosarcoma | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0019207 | Hepatoma, Morris | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0019208 | Hepatoma, Novikoff | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0019562 | Von Hippel-Lindau Syndrome | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0020502 | Hyperparathyroidism | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0020507 | Hyperplasia | 2 | CTD_human |
| ENSG00000110092 | CCND1 | C0021846 | Intestinal Polyps | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0022665 | Kidney Neoplasm | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0023418 | leukemia | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0023903 | Liver neoplasms | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0023904 | Liver Neoplasms, Experimental | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0024121 | Lung Neoplasms | 2 | CTD_human |
| ENSG00000110092 | CCND1 | C0024623 | Malignant neoplasm of stomach | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0024667 | Animal Mammary Neoplasms | 4 | CTD_human |
| ENSG00000110092 | CCND1 | C0024668 | Mammary Neoplasms, Experimental | 3 | CTD_human |
| ENSG00000110092 | CCND1 | C0026764 | Multiple Myeloma | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0027659 | Neoplasms, Experimental | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0030354 | Papilloma | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0032927 | Precancerous Conditions | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0036095 | Salivary Gland Neoplasms | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0036341 | Schizophrenia | 1 | PSYGENET |
| ENSG00000110092 | CCND1 | C0038356 | Stomach Neoplasms | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0040136 | Thyroid Neoplasm | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0041696 | Unipolar Depression | 1 | PSYGENET |
| ENSG00000110092 | CCND1 | C0042076 | Urologic Neoplasms | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0086404 | Experimental Hepatoma | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0151468 | Thyroid Gland Follicular Adenoma | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0151744 | Myocardial Ischemia | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0153437 | Malignant neoplasm of cecum | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0153633 | Malignant neoplasm of brain | 2 | CTD_human |
| ENSG00000110092 | CCND1 | C0205641 | Adenocarcinoma, Basal Cell | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0205642 | Adenocarcinoma, Oxyphilic | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0205643 | Carcinoma, Cribriform | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0205644 | Carcinoma, Granular Cell | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0205645 | Adenocarcinoma, Tubular | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0205696 | Anaplastic carcinoma | 4 | CTD_human |
| ENSG00000110092 | CCND1 | C0205697 | Carcinoma, Spindle-Cell | 4 | CTD_human |
| ENSG00000110092 | CCND1 | C0205698 | Undifferentiated carcinoma | 4 | CTD_human |
| ENSG00000110092 | CCND1 | C0205699 | Carcinomatosis | 4 | CTD_human |
| ENSG00000110092 | CCND1 | C0205874 | Papilloma, Squamous Cell | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0205875 | Papillomatosis | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0220636 | Malignant neoplasm of salivary gland | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0235874 | Disease Exacerbation | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0242379 | Malignant neoplasm of lung | 2 | CTD_human |
| ENSG00000110092 | CCND1 | C0279626 | Squamous cell carcinoma of esophagus | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0282313 | Condition, Preneoplastic | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0334634 | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 2 | CTD_human |
| ENSG00000110092 | CCND1 | C0345904 | Malignant neoplasm of liver | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0376358 | Malignant neoplasm of prostate | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0476089 | Endometrial Carcinoma | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0496899 | Benign neoplasm of brain, unspecified | 2 | CTD_human |
| ENSG00000110092 | CCND1 | C0546837 | Malignant neoplasm of esophagus | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0549473 | Thyroid carcinoma | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0678222 | Breast Carcinoma | 6 | CTD_human |
| ENSG00000110092 | CCND1 | C0740457 | Malignant neoplasm of kidney | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0750974 | Brain Tumor, Primary | 2 | CTD_human |
| ENSG00000110092 | CCND1 | C0750977 | Recurrent Brain Neoplasm | 2 | CTD_human |
| ENSG00000110092 | CCND1 | C0750979 | Primary malignant neoplasm of brain | 2 | CTD_human |
| ENSG00000110092 | CCND1 | C0751571 | Cancer of Urinary Tract | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C0751958 | Lymphoma, Lymphocytic, Intermediate | 2 | CTD_human |
| ENSG00000110092 | CCND1 | C0919532 | Genomic Instability | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C1168401 | Squamous cell carcinoma of the head and neck | 2 | CTD_human |
| ENSG00000110092 | CCND1 | C1257925 | Mammary Carcinoma, Animal | 4 | CTD_human |
| ENSG00000110092 | CCND1 | C1257931 | Mammary Neoplasms, Human | 6 | CTD_human |
| ENSG00000110092 | CCND1 | C1269683 | Major Depressive Disorder | 1 | PSYGENET |
| ENSG00000110092 | CCND1 | C1458155 | Mammary Neoplasms | 6 | CTD_human |
| ENSG00000110092 | CCND1 | C1527390 | Neoplasms, Intracranial | 2 | CTD_human |
| ENSG00000110092 | CCND1 | C1708349 | Hereditary Diffuse Gastric Cancer | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C2239176 | Liver carcinoma | 5 | CTD_human |
| ENSG00000110092 | CCND1 | C2931822 | Nasopharyngeal carcinoma | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C4048328 | cervical cancer | 1 | CTD_human |
| ENSG00000110092 | CCND1 | C4704874 | Mammary Carcinoma, Human | 6 | CTD_human |
